Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD)
Displaying entries 5476 - 5500 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ▼ ChEBI ID Exact Mass Formula
Diacylglycerophosphoinositolglycans LMGP15010018
  • 2'-O-(alpha-D-Manp)-(1,2-dioctadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:0/18:0)
126457386 1028.641258 C51H97O18P
Diacylglycerophosphoinositolglycans LMGP15010017
  • 2'-O-(alpha-D-Manp)-(1-octadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:0/16:2(9Z,12Z))
126457385 996.578658 C49H89O18P
Diacylglycerophosphoinositolglycans LMGP15010016
  • 2'-O-(alpha-D-Manp)-(1-octadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:0/16:1(9Z))
126457384 998.594308 C49H91O18P
Diacylglycerophosphoinositolglycans LMGP15010015
  • 2'-O-(alpha-D-Manp)-(1-octadecanoyl-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:0/16:0)
126457383 1000.609958 C49H93O18P
Diacylglycerophosphoinositolglycans LMGP15010014
  • 2'-O-(alpha-D-Manp)-(1-octadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:0/14:0)
126457382 972.578658 C47H89O18P
Diacylglycerophosphoinositolglycans LMGP15010013
  • 2'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(17:0/18:1(9Z))
126457381 1012.609958 C50H93O18P
Diacylglycerophosphoinositolglycans LMGP15010012
  • 2'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(17:0/18:0)
126457380 1014.625608 C50H95O18P
Diacylglycerophosphoinositolglycans LMGP15010011
  • 2'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(17:0/16:2(9Z,12Z))
126457379 982.563008 C48H87O18P
Diacylglycerophosphoinositolglycans LMGP15010010
  • 2'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(17:0/16:1(9Z))
126457378 984.578658 C48H89O18P
Diacylglycerophosphoinositolglycans LMGP15010009
  • 2'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(17:0/16:0)
126457377 986.594308 C48H91O18P
Diacylglycerophosphoinositolglycans LMGP15010008
  • 2'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(17:0/14:0)
126457376 958.563008 C46H87O18P
Diacylglycerophosphoinositolglycans LMGP15010007
  • 2'-O-(alpha-D-Manp)-(1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(16:0/18:1(9Z))
126457375 998.594308 C49H91O18P
Diacylglycerophosphoinositolglycans LMGP15010006
  • 2'-O-(alpha-D-Manp)-(1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(16:0/18:0)
126457374 1000.609958 C49H93O18P
Diacylglycerophosphoinositolglycans LMGP15010005
  • 2'-O-(alpha-D-Manp)-(1-hexadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(16:0/16:2(9Z,12Z))
126457373 968.547358 C47H85O18P
Diacylglycerophosphoinositolglycans LMGP15010004
  • 2'-O-(alpha-D-Manp)-(1-hexadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(16:0/16:1(9Z))
126457372 970.563008 C47H87O18P
Diacylglycerophosphoinositolglycans LMGP15010003
  • 2'-O-(alpha-D-Manp)-(1,2-dihexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(16:0/16:0)
126457371 972.578658 C47H89O18P
Diacylglycerophosphoinositolglycans LMGP15010002
  • 2'-O-(alpha-D-Manp)-(1-hexadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(16:0/14:0)
126457370 944.547358 C45H85O18P
Simple Glc series LMSP0501AA37
  • GlcCer(d18:2/22:0)
  • N-(docosanoyl)-1beta-glucosyl-4E,14Z-sphingadienine
124079387 132461 781.643169 C46H87NO8
Simple Glc series LMSP0501AC22
  • GalCer(d18:2/22:0)
  • N-(docosanoyl)-1-beta-galactosyl-4E,14Z-sphingadienine
124079386 132459 781.643169 C46H87NO8
Simple Glc series LMSP0501AA36
  • GlcCer(d18:2/21:0)
  • N-(heneicosanoyl)-1beta-glucosyl-4E,14Z-sphingadienine
124079385 132458 767.627519 C45H85NO8
Simple Glc series LMSP0501AC21
  • GalCer(d18:2/21:0)
  • N-(heneicosanoyl)-1-beta-galactosyl-4E,14Z-sphingadienine
124079384 132457 767.627519 C45H85NO8
Simple Glc series LMSP0501AA34
  • GlcCer(d18:2/20:0)
  • N-(eicosanoyl)-1beta-glucosyl-4E,14Z-sphingadienine
124079383 132456 753.611869 C44H83NO8
Simple Glc series LMSP0501AC19
  • GalCer(d18:2/20:0)
  • N-(eicosanoyl)-1-beta-galactosyl-4E,14Z-sphingadienine
124079382 132455 753.611869 C44H83NO8
Simple Glc series LMSP0501AC09
  • GalCer(d16:1/22:0)
  • N-(docosanoyl)-1-beta-galactosyl-hexadecasphing-4-enine
124079380 132453 755.627519 C44H85NO8
Diacylaminosugars LMSL01020001
  • 2,3-bis-(3R-hydroxy-tetradecanoyl)-alphaD-glucosamine-1-phosphate
  • Lipid X
123907 16942 711.432267 C34H66NO12P

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024